Literature DB >> 25267551

Finite-sample corrected generalized estimating equation of population average treatment effects in stepped wedge cluster randomized trials.

JoAnna M Scott1, Allan deCamp2,3, Michal Juraska2, Michael P Fay4, Peter B Gilbert2,3.   

Abstract

Stepped wedge designs are increasingly commonplace and advantageous for cluster randomized trials when it is both unethical to assign placebo, and it is logistically difficult to allocate an intervention simultaneously to many clusters. We study marginal mean models fit with generalized estimating equations for assessing treatment effectiveness in stepped wedge cluster randomized trials. This approach has advantages over the more commonly used mixed models that (1) the population-average parameters have an important interpretation for public health applications and (2) they avoid untestable assumptions on latent variable distributions and avoid parametric assumptions about error distributions, therefore, providing more robust evidence on treatment effects. However, cluster randomized trials typically have a small number of clusters, rendering the standard generalized estimating equation sandwich variance estimator biased and highly variable and hence yielding incorrect inferences. We study the usual asymptotic generalized estimating equation inferences (i.e., using sandwich variance estimators and asymptotic normality) and four small-sample corrections to generalized estimating equation for stepped wedge cluster randomized trials and for parallel cluster randomized trials as a comparison. We show by simulation that the small-sample corrections provide improvement, with one correction appearing to provide at least nominal coverage even with only 10 clusters per group. These results demonstrate the viability of the marginal mean approach for both stepped wedge and parallel cluster randomized trials. We also study the comparative performance of the corrected methods for stepped wedge and parallel designs, and describe how the methods can accommodate interval censoring of individual failure times and incorporate semiparametric efficient estimators.

Entities:  

Keywords:  Phase 3; Phase 4; Vaccine efficacy trial; cluster randomization; generalized estimating equations; marginal mean model; small-sample variance correction

Mesh:

Substances:

Year:  2014        PMID: 25267551      PMCID: PMC4411204          DOI: 10.1177/0962280214552092

Source DB:  PubMed          Journal:  Stat Methods Med Res        ISSN: 0962-2802            Impact factor:   3.021


  36 in total

Review 1.  Selected statistical issues in group randomized trials.

Authors:  Z Feng; P Diehr; A Peterson; D McLerran
Journal:  Annu Rev Public Health       Date:  2001       Impact factor: 21.981

2.  A covariance estimator for GEE with improved small-sample properties.

Authors:  L A Mancl; T A DeRouen
Journal:  Biometrics       Date:  2001-03       Impact factor: 2.571

3.  Collaborative double robust targeted maximum likelihood estimation.

Authors:  Mark J van der Laan; Susan Gruber
Journal:  Int J Biostat       Date:  2010-05-17       Impact factor: 0.968

4.  The MEMA kwa Vijana project: design of a community randomised trial of an innovative adolescent sexual health intervention in rural Tanzania.

Authors:  Richard J Hayes; John Changalucha; David A Ross; Awene Gavyole; Jim Todd; Angela I N Obasi; Mary L Plummer; Daniel Wight; David C Mabey; Heiner Grosskurth
Journal:  Contemp Clin Trials       Date:  2005-08       Impact factor: 2.226

5.  A comparison of two bias-corrected covariance estimators for generalized estimating equations.

Authors:  Bing Lu; John S Preisser; Bahjat F Qaqish; Chirayath Suchindran; Shrikant I Bangdiwala; Mark Wolfson
Journal:  Biometrics       Date:  2007-09       Impact factor: 2.571

6.  To GEE or not to GEE: comparing population average and mixed models for estimating the associations between neighborhood risk factors and health.

Authors:  Alan E Hubbard; Jennifer Ahern; Nancy L Fleischer; Mark Van der Laan; Sheri A Lippman; Nicholas Jewell; Tim Bruckner; William A Satariano
Journal:  Epidemiology       Date:  2010-07       Impact factor: 4.822

7.  Hutchinson Smoking Prevention Project: long-term randomized trial in school-based tobacco use prevention--results on smoking.

Authors:  A V Peterson; K A Kealey; S L Mann; P M Marek; I G Sarason
Journal:  J Natl Cancer Inst       Date:  2000-12-20       Impact factor: 13.506

8.  Effect of routine isoniazid preventive therapy on tuberculosis incidence among HIV-infected men in South Africa: a novel randomized incremental recruitment study.

Authors:  Alison D Grant; Salome Charalambous; Katherine L Fielding; John H Day; Elizabeth L Corbett; Richard E Chaisson; Kevin M De Cock; Richard J Hayes; Gavin J Churchyard
Journal:  JAMA       Date:  2005-06-08       Impact factor: 56.272

9.  Uptake of workplace HIV counselling and testing: a cluster-randomised trial in Zimbabwe.

Authors:  Elizabeth L Corbett; Ethel Dauya; Ronnie Matambo; Yin Bun Cheung; Beauty Makamure; Mary T Bassett; Steven Chandiwana; Shungu Munyati; Peter R Mason; Anthony E Butterworth; Peter Godfrey-Faussett; Richard J Hayes
Journal:  PLoS Med       Date:  2006-07       Impact factor: 11.069

Review 10.  The stepped wedge trial design: a systematic review.

Authors:  Celia A Brown; Richard J Lilford
Journal:  BMC Med Res Methodol       Date:  2006-11-08       Impact factor: 4.615

View more
  27 in total

1.  Novel methods for the analysis of stepped wedge cluster randomized trials.

Authors:  Lee Kennedy-Shaffer; Victor de Gruttola; Marc Lipsitch
Journal:  Stat Med       Date:  2019-12-26       Impact factor: 2.373

2.  Analysis of stepped wedge cluster randomized trials in the presence of a time-varying treatment effect.

Authors:  Avi Kenny; Emily C Voldal; Fan Xia; Patrick J Heagerty; James P Hughes
Journal:  Stat Med       Date:  2022-06-30       Impact factor: 2.497

Review 3.  Stepped Wedge Cluster Randomized Trials: A Methodological Overview.

Authors:  Fan Li; Rui Wang
Journal:  World Neurosurg       Date:  2022-05       Impact factor: 2.210

4.  Considerations Before Selecting a Stepped-Wedge Cluster Randomized Trial Design for a Practice Improvement Study.

Authors:  Ann M Nguyen; Charles M Cleland; L Miriam Dickinson; Michael P Barry; Samuel Cykert; F Daniel Duffy; Anton J Kuzel; Stephan R Lindner; Michael L Parchman; Donna R Shelley; Theresa L Walunas
Journal:  Ann Fam Med       Date:  2022 May-Jun       Impact factor: 5.707

Review 5.  Design and analysis of group-randomized trials in cancer: A review of current practices.

Authors:  David M Murray; Sherri L Pals; Stephanie M George; Andrey Kuzmichev; Gabriel Y Lai; Jocelyn A Lee; Ranell L Myles; Shakira M Nelson
Journal:  Prev Med       Date:  2018-03-16       Impact factor: 4.018

Review 6.  Current issues in the design and analysis of stepped wedge trials.

Authors:  James P Hughes; Tanya S Granston; Patrick J Heagerty
Journal:  Contemp Clin Trials       Date:  2015-08-03       Impact factor: 2.226

7.  Design and analysis considerations for cohort stepped wedge cluster randomized trials with a decay correlation structure.

Authors:  Fan Li
Journal:  Stat Med       Date:  2019-12-04       Impact factor: 2.373

8.  Power and sample size requirements for GEE analyses of cluster randomized crossover trials.

Authors:  Fan Li; Andrew B Forbes; Elizabeth L Turner; John S Preisser
Journal:  Stat Med       Date:  2018-10-08       Impact factor: 2.373

9.  Randomization-based inference for a marginal treatment effect in stepped wedge cluster randomized trials.

Authors:  Dustin J Rabideau; Rui Wang
Journal:  Stat Med       Date:  2021-05-21       Impact factor: 2.497

10.  Randomization-based confidence intervals for cluster randomized trials.

Authors:  Dustin J Rabideau; Rui Wang
Journal:  Biostatistics       Date:  2021-10-13       Impact factor: 5.899

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.